Can technetium-99m-mercaptoacetyltriglycine replace technetium-99m-dimercaptosuccinic acid in the exclusion of a focal renal defect?

J Nucl Med. 1992 Dec;33(12):2090-3.

Abstract

The presence of focal renal damage dictates different management of a child with urinary tract infection (UTI) compared with children who have normal kidneys. Technetium-99m-dimercaptosuccinic (DMSA) has a high sensitivity in the detection of a focal defect, and allows estimation of differential function. The introduction of 99mTc-MAG3 with high renal extraction suggests that this may be useful in children with UTI but its role remains speculative. Fifty-nine children with previous UTI underwent both 99mTc-DMSA and MAG3 within 4 wk of each other. Differential function and assessment of the images were undertaken. There is close correlation (R2 = 0.97) between the differential function. Analysis of the 99mTc-DMSA and functional MAG3 images showed that the functional image had a specificity of 88% and a sensitivity of 88% in the detection of a focal parenchymal defect. Technetium-99m-MAG3 in the clinical setting of a child with UTl allows accurate assessment of differential function and a high probability of detecting a focal renal abnormality.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Kidney Diseases / diagnostic imaging*
  • Kidney Diseases / physiopathology
  • Male
  • Organotechnetium Compounds*
  • Radionuclide Imaging
  • Sensitivity and Specificity
  • Succimer*
  • Technetium Tc 99m Dimercaptosuccinic Acid
  • Technetium Tc 99m Mertiatide*

Substances

  • Organotechnetium Compounds
  • Technetium Tc 99m Mertiatide
  • Technetium Tc 99m Dimercaptosuccinic Acid
  • Succimer